Table 2.
Baseline characteristics and comparison of the changes within and between groups following the interventiona
| Variable | Group | |||||||
|---|---|---|---|---|---|---|---|---|
| Intervention (n = 28) | Control (n = 28) | Between-group P** value | ||||||
| Before | After | P* value | Before | After | P* value | Before | After | |
| 25(OH)D (nmol L−1) | 87.1 (28.55) | 127.92 (24.93) | < 0.001 | 73.64 (31.94) | 78.77 (27.05) | 0.26 | 0.10 | < 0.001 |
| Serum iPTH (pg mL−1) | 13.26 (14.39) | 13.43 (9.30) | 0.07 | 11.08 (8.33) | 16.18 (7.92) | < 0.001 | 0.64 | 0.07 |
| hs-CRP (mg L−1) | 4.40 (3.03) | 4.67 (3.39) | 0.7 | 5.29 (4.57) | 4.07 (3.71) | 0.13 | 0.97 | 0.18 |
| IL-1β (pg mL−1) | 39.83 (33.15) | 41.04 (36.45) | 0.67 | 30.85 (34.15) | 33.76 (28.80) | 0.41 | 0.15 | 0.76 |
| IL-6 pg mL−1) | 2.08 (0.63) | 1.98 (0.44) | 0.85 | 3.23 (5.27) | 3.39 (6.66) | 0.13 | 0.26 | 0.31 |
| BDI-II score | 23.86 (5.49) | 12.11 (6.12) | < 0.001 | 21.79 (5.74) | 18.18 (12.82) | 0.053 | 0.23 | 0.003 |
25(OH)D 25-hydroxyvitamin D, iPTH intact parathormone, hs-CRP high-sensitivity C-reactive protein, IL-1β interleukin-1β, IL-6 interleukin-6, BDI-II Beck Depression Inventory-II
aAll values are means (± SDs)
*Denotes the significance of within-group changes, paired sample t-test (for normal distribution), Wilcoxon test (for non-normal distribution)
**Denotes the significance of between-group changes, independent sample t-test (for normal distribution), Mann–Whitney test (for non-normal distribution)